US2022268966A1PendingUtilityA1

Biomedical devices containing internal wetting agents

87
Assignee: JOHNSON & JOHNSON VISION CAREPriority: Sep 10, 2001Filed: May 13, 2022Published: Aug 25, 2022
Est. expirySep 10, 2021(expired)· nominal 20-yr term from priority
Inventors:Kevin P. MccabeFrank MolockGregory A. HillAzaam AlliRobert B. SteffenDouglas G. VanderlaanJames D. Ford
C08F 290/068A61L 2430/16G02C 7/022A61L 27/52C08F 265/04A61L 27/26A61L 27/18C08F 271/02G02B 1/043C08F 283/12C08F 291/00C08F 283/06C08F 271/00C08F 290/06C08F 251/00
87
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

This invention includes a wettable biomedical device containing a high molecular weight hydrophilic polymer and a hydroxyl-functionalized silicone-containing monomer.

Claims

exact text as granted — not AI-modified
1 - 137 . (canceled) 
     
     
         138 . An ophthalmic device comprising at least one hydroxyl-functionalized silicone-containing monomer and an amount of high molecular weight hydrophilic polymer sufficient to provide said device, without a surface treatment, with tear film break up time after about one day of wear of at least about 7 seconds. 
     
     
         139 - 162 . (canceled)

Join the waitlist — get patent alerts

Track US2022268966A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.